Skip to main content

Table 1 Demographic and clinical characteristics of the sample

From: Validity of subjective versus objective quality of life assessment in people with schizophrenia

Baseline variables (N = 80)
Gender, Male (%) 54 (68%)
Smoking, Yes (%) 61 (76%)
Current drug use, Yes (%) 23 (29%)
Current alcohol use, Yes (%) 23 (29%)
  Mean (SD) Median Range
Age (yr) 39.8 (10.9) 40.1 18.5 - 60.1
Duration of Illness (yr) 13.16 (11.24) 9.04 0 - 38
Number of previous hospitalisations 4.78 (5.89) 3.00 0 - 40
Patient-rated QoL (LQOLP average) 3.95 (1.48) 3.50 1 – 7
Assessor-rated QoL (QLS total score) 41.61 (17.55) 39.00 11 – 91
Insight (BIS) 12.15 (3.45) 12.00 2 – 16
Depression (CDSS) 9.04 (6.21) 8.00 0 – 22
Positive symptoms (PANSS) 16.89 (6.14) 16.00 7 – 32
Negative symptoms (PANSS) 20.61 (5.49) 20.50 9 – 39
General psychopathology (PANSS) 40.33 (9.74) 40.50 22 - 64
Total symptom score (PANSS) 77.83 (17.44) 76.50 45 – 128
Adherence Rating (Kemp) 5.04 (1.44) 5.00 1 - 7
Drug Attitude (DAI) +11.08 (10.95) +10.00 −18 - +30
Simpson-Angus 4.64 (4.23) 4.00 0 – 22
Barnes Akathisia 3.63 (3.18) 3.50 0 – 11
AIMS 1.60 (2.59) 1.00 0 – 15
Non-neurological side effects (ANNSERS) 19.37 (10.13) 20.00 1 – 39
Body Mass Index (BMI) 26.83 (6.33) 26.10 16.5 – 50